Omalizumab in treatment-resistant chronic spontaneous urticaria

Indian Journal of Dermatology

Volumn 56, Issue 4, 2011, Pages 444-

  Godse, Kiran V ^a  

^a Shree Skin Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E; OMALIZUMAB;

ANGIONEUROTIC EDEMA; CHRONIC SPONTANEOUS URTICARIA; CLINICAL ARTICLE; DRUG INDUCED HEADACHE; FATIGUE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; SYMPTOM; TREATMENT RESPONSE; URTICARIA;

EID: 80052872083     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.84737     Document Type: Letter

References (7)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gime'nez-Arnau A et al. EAACI/GA 2 LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1417-26.
2. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet P, Bousquet J et al. Unmet clinical needs in chronic spontaneous urticaria. A GA 2 LEN task force report(1). Allergy 2011;66:317-30.
3. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gime'nez-Arnau A et al. EAACI/GA 2 LEN/EDF/WAO guideline: Management of urticaria. Allergy 2009;64:1427-43.
4. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008;122:569-73.
5. Godse KV. Omalizumab in severe chronic urticaria. Indian J Dermatol Venereol Leprol 2008;74:157-8.
6. Groffik A, Mitzel-Kaoukhov H, Magerl M, Maurer M, Staubach P. Omalizumab-An effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy 2011;66:303-5.
7. Metz M, Altrichter S, Ardelean E, Kessler B, Krause K, Magerl M, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011;154:177-80.